Source: BioPortfolio

MSD: Meso Scale Discovery Launches Synuclein Assay for Parkinsons Disease Research

Meso Scale Discovery a division of Meso Scale Diagnostics LLC. MSD today launched a new immunoassay validated for the detection of alphasynuclein in human serum plasma cerebral spinal fluid saliva and whole blood. Development of this assay was supported by...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
CEO Avatar

President & CEO

Jacob Wohlstadter

CEO Approval Rating

89/100

Read more